64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery. The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specific focus on those used for cell and gene therapies.

ALICE Technologies is the world's first AI-powered construction simulation platform. Founded in 2015 based on research from Stanford University, ALICE leverages artificial intelligence to analyze a project's complex building requirements, generate highly efficient building schedules, and tune those schedules as needed during construction. ALICE enables contractors and owners to plan, bid, and build more effectively, reducing construction times and labor costs by $30 million for a typical $500 million construction project. ALICE Technologies works with construction leaders in the infrastructure and commercial construction segments, such as Parsons, HDCC, and Kajima Corporation. Learn more at www.alicetechnologies.com.

ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.

Beeflow applies scientific knowledge and technologies to bee pollination. By providing professional pollination services to farmers, we increase crop yields while reducing bee population decline. Since we first started 4 years ago in Argentina, we have increased between 20-90% crop yields in Blueberries, Almonds, Raspberries and Kiwifruit. In 2017 we launched our company in the United States and we’re growing fast our team based in Ventura County, CA.

Cambrian Biopharma is a private, clinical-stage biopharmaceutical company focused on developing therapies to prevent and cure age-related diseases. Cambrian is based in New York City with operations across the US and Europe. Cambrian Biopharma is a biotech venture capital holding company that helps scientists transmit their discoveries from the lab into the clinic. Cambrian is uniquely focused on a specific field of biomedical research: the biology of aging, also known as geroscience. Cambrian is built on an emerging business model that we call a ‘Distributed R&D Company’ or ‘DisCo’ that blends the best aspects of the venture capital firm with the capital efficient, agile domain expertise of a mid-sized biotech company. We partner with academic geroscientists to build companies, manage preclinical drug discovery, and finance clinical trials. We have launched 10 companies with leading geroscientists globally. Founded in 2019, Cambrian is a team of over 20 scientist-entrepreneurs, venture capitalists, pharma veterans, and drug hunters located in New York, San Diego, Oxford, Sydney, Frankfurt and London.

Commonwealth Fusion Systems (CFS) has the fastest, lowest cost path to commercial fusion energy. CFS is collaborating with MIT to leverage decades of research combined with new groundbreaking high-temperature superconducting (HTS) magnet technology. HTS magnets will enable compact fusion power plants that can be constructed faster and at lower cost. CFS is now building SPARC, the world's first commercially relevant, net energy fusion demonstration device. SPARC will pave the way for the first fusion power plant, ARC, that will produce power on the grid. The ultimate mission is to deploy fusion power plants to meet global decarbonization goals as fast as possible. CFS has assembled a team of leaders in tough tech, fusion science, and manufacturing with a track record of rapid execution. Supported by the world’s leading investors, CFS is uniquely positioned to deliver limitless, clean, fusion power to combat climate change.

Developing novel catalysts and processes that enable sustainable chemistry and e-fuels.

Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI.

Earthshot Labs an open-source community, public benefit technology company, and sustainable asset manager. We are developing the first open-source unified land use model for landowners, investors, and policy makers to scale regenerative land management globally.

Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.

Gameto is a new breed of biotechnology firm dedicated to better understanding and treating infertility and menopause. The company aims to leverage the allogeneic human cellular derivatives of their platform to therapeutic applications for assisted fertility and menopause. Gameto was founded in 2020 and is based in New York.

Traditional cameras rely on an imaging lens which typically consists of several lens elements and a light sensitive sensor. Cameras have been built like this since 1816. Glass has been historically used to make high quality optical elements. We are replacing these elements with deep neural networks that give extreme flexibility when designing our cameras. It allows us to squeeze a huge sensor into an ultra thin module that fits perfectly into a mobile device without the need for protruding bumps. Our cameras bring SLR image quality into your pocket.